Active substanceLicorice rootsLicorice roots
Similar drugsTo uncover
  • Licorice roots
    raw materials. inwards 
    LEK S +, LLC     Russia
  • Licorice roots
    powder inwards 
    St.-MEDIFARM, CJSC     Russia
  • Licorice roots
    raw materials. inwards 
  • Licorice roots
    raw materials. inwards 
  • Licorice roots
    powder inwards 
    LEK S +, LLC     Russia
  • Licorice roots
    raw materials. inwards 
  • Licorice roots
    raw materials. inwards 
    FITOFARM PKF, LLC     Russia
  • Licorice syrup
    syrup inwards 
  • Licorice syrup
    syrup inwards 
  • Licorice syrup
    syrup inwards 
  • Licorice syrup
    syrup inwards 
  • Licorice syrup
    syrup inwards 
  • Licorice syrup
    syrup inwards 
    SAMARAHEDPROM, JSC     Russia
  • Licorice syrup
    syrup inwards 
    VIFITEH, CJSC     Russia
  • Licorice syrup
    syrup inwards 
    BEGRIF, LTD     Russia
  • Licorice syrup
    syrup inwards 
    ALTAYVITAMINS, CJSC     Russia
  • Licorice syrup
    syrup inwards 
  • Licorice syrup
    syrup inwards 
  • Licorice syrup
    syrup inwards 
    ECOLAB, CJSC     Russia
  • Licorice syrup
    syrup inwards 
  • Licorice syrup
    syrup inwards 
  • Licorice extract is thick
    extract inwards 
  • Licorice extract dry
    raw materials.
  • The licorice root extract is thick
    extractraw materials.
  • Dosage form: & nbspsyrup
    Composition:

    Composition per 100 g of the preparation

    Active component

    Licorice extract thick with glycyrrhizic acid content in terms of dry matter 19.0% - 4 g

    Excipients

    Sugar (sucrose) -55 g

    Purified Water -31 g

    Ethyl ethyl alcohol 90% (ethanol) - 10 g.


    Description:
    A thick, uniform liquid from light brown to dark brown with a characteristic odor.

    Pharmacotherapeutic group:expectorant
    ATX: & nbsp

    V.03.A.X   Other medications

    Pharmacodynamics:
    Has an expectorant effect, caused, first of all, by the presence of glycyrrhizin, which enhances the secretory function of the mucous membranes of the upper respiratory tract.

    Pharmacokinetics:data not available
    Indications:
    Indications for use
    Used in adults and children as an expectorant for diseases of the upper respiratory tract, accompanied by cough, mainly in the presence of poorly separated, thick and viscous secretion (especially in children and the elderly).

    Contraindications:
    Increased individual sensitivity to the drug components, sugarase / isomaltase deficiency, fructose intolerance, glucose-galactose malabsorption, pregnancy, the period of breastfeeding, bronchial asthma, gastritis, peptic ulcer of the stomach and duodenal ulcer during exacerbation.

    Carefully:
    Liver diseases, alcoholism, craniocerebral trauma, brain diseases, diabetes mellitus; childhood.
    If you have any of these diseases, consult a doctor before taking the drug.

    Dosing and Administration:
    Inside. Adults and children over 12 years of 1 teaspoon (previously diluted in 1/2 cup of water) 3 times a day. , - .
    Children under 2 years - 1-2 drops (previously diluted in 1 teaspoon 'water') 3 times a day. . '
    Children from 2 to 6 years - 2-10 drops (previously diluted in 1 teaspoon of water) 3 times a day.
    Children from 6 to 12 years - 50 drops (previously diluted in 1/2 cup water) 3 times a day. .
    The course of treatment is 7-10 days. The expediency of conducting a second course of treatment is determined by the doctor.
    In the presence of poorly separated sputum and to facilitate expectoration, an abundant warm drink is recommended.

    Side effects:
    Allergic reactions are possible; in some cases, there may be dyspepsia (diarrhea). With prolonged use, hypokalemia, increased blood pressure, the appearance of peripheral edema due to water-salt metabolism disorders are possible.

    If any of the side effects listed in the manual are aggravated, or if you notice any other side effects not listed in the instructions, tell your doctor.
    Overdose:
    When using the drug in doses exceeding recommended, it is possible to increase dose-dependent side effects.

    Interaction:
    . The drug can be prescribed simultaneously with the drugs used in the treatment of bronchopulmonary diseases.
    Do not use simultaneously with drugs containing codeine and other antitussive drugs, as it hinders the coughing up of diluted sputum.

    Special instructions:
    Information for diabetics: one teaspoon of the drug contains 0.29 bread units (XE), in 1 drop - 0.0024 XE. >
    The maximum single dose of the drug for adults contains 0.54 g of absolute alcohol, the maximum daily dose is 1.62 g of absolute alcohol, in 1 drop (for children) 0.0046 g of absolute alcohol.


    Effect on the ability to drive transp. cf. and fur:During the period of treatment, care must be taken when driving vehicles and engaging in other potentially hazardous activities requiring increased attention and speed of psychomotor reactions. .
    Form release / dosage:Syrup. To 100 g in bottles of orange glass or bottles of polyethylene terephthalate. Each vial with instructions for use in a pack of cardboard; 36 bottles together. with an equal number of instructions for use in a box or box of cardboard.
    Packaging:Syrup. To 100 g in bottles of orange glass or bottles of polyethylene terephthalate. Each vial with instructions for use in a pack of cardboard; 36 bottles together. froman equal number of instructions for use in a box or box of cardboard.
    Storage conditions:
    In the dark place at a temperature of 15 to 25 ° C.
    Keep out of the reach of children.

    Shelf life:
    2 years.
    Do not use after the expiration date.

    Terms of leave from pharmacies:Without recipe
    Registration number:LS-000209
    Date of registration:24.05.2010 / 19.11.2013
    The owner of the registration certificate:VIFITEH, CJSC VIFITEH, CJSC Russia
    Manufacturer: & nbsp
    Representation: & nbspVIFITEH, CJSCVIFITEH, CJSC
    Information update date: & nbsp07.08.2015
    Illustrated instructions
      Instructions
      Up